The Trump administration finalized long-planned overhauls to the Stark and anti-kickback laws Friday, and the changes are getting mixed reviews from providers. Hospital groups including the American Hospital Association (AHA) and the Federation of American Hospitals (FAH) were optimistic about the regulatory changes, while physician groups such as the American Medical Group Association (AMGA) expressed skepticism.

Cancer care has seen incredible progress over the past few decades, both in treatment options and in the development of innovative tools and resources that help oncologists select optimal treatments. Among the significant advancements in this area has been the emergence of treatment guidelines and clinical pathways1 that have led to improved patient outcomes and

Invitae (NYSE: NVTA), a leading medical genetics company, today presented study findings that show nine percent of patients with pancreatic cancer had genetic changes in DNA damage repair (DDR) genes that would make them eligible for PARP inhibitor therapy or clinical treatment trials. Despite professional guidelines that recommend testing for all pancreatic cancer patients, it

University of Virginia Cancer Center researchers have identified a gene responsible for the spread of so-called “triple-negative” breast cancer to other parts of the body – a process called metastasis – and developed a potential way to stop it. Triple-negative breast cancer is an aggressive form of breast cancer that accounts for 40,000 deaths in the

The potential for precision medicine to revolutionize care in the development of new treatments has only just begun. Translating these initial successes (eg, targeted therapies in lung cancer) to a larger scale will require a coordinated and sustained national effort and must include careful attention to the broader public health impact. The lack of inclusion

The lack of therapeutic options and support networks for patients with ovarian cancer results in uncertainty and disruption for patients with the disease, as well as for their caregivers, according to a new thematic analysis of patient and caregiver sentiments. The research, conducted in Australia, was published in the journal Psycho-Oncology. Corresponding author Louise Sharpe,

Even as the coronavirus pandemic has postponed the delivery of many kinds of health care, a new study suggests that delaying cancer treatment by even a month can raise your risk of dying by 6% to 13%, and that risk keeps rising the longer treatment is delayed. The increased risk of death for seven types

Eight years ago, the Affordable Care Act barely survived its first encounter with the Supreme Court. On Tuesday, a significantly more conservative court will hear arguments in a case brought by Republican state officials, backed by the Trump administration, seeking to destroy it. At stake are health insurance for millions of people, protections for pre-existing

Over the weekend we received the news that game show host, Alex Trebek passed away after his battle with cancer. Millions of Americans watched him on television as the host of the hit show Jeopardy! which began first aired in 1984. In March of 2019, Trebek delivered sad news to his fans when he announced

It wasn’t long ago that the prognosis for patients with lung cancer was dismal, with little hope for patients. However, the advances in immunotherapies and targeted therapies have paved the way for promising outcomes not only in patients with lung cancer but many other cancer types that have followed suit based on the positive findings